title: [Transcutaneous aortic valve implantation].
abstract: Due to increasing life expectancy in the coming decades the number of elderly patients with aortic valve stenosis (AS) and various concomitant diseases will increase. Conventional surgical aortic valve replacement represents the treatment of choice in patients with severe and symptomatic AS. Transfemoral and transapical aortic valve implantation (T-AVI) has evolved as a standard procedure for patients with severe AS who are technically inoperable or at very high risk for surgical valve replacement. The T-AVI approach has been shown to be superior to the standard medical treatment in these high-risk patients. All patients to be considered for T-AVI should be discussed in a consensus conference consisting of cardiac surgeons and cardiologists (heart team).
authors.affiliation: Abteilung für Kardiologie, Kerckhoff-Klinik, Bad Nauheim, Deutschland. h.moellmann@kerckhoff-klinik.de
authors.forename: H
authors.initials: H
authors.lastname: Möllmann
authors.forename: C
authors.initials: C
authors.lastname: Liebetrau
authors.forename: H
authors.initials: H
authors.lastname: Nef
authors.forename: J
authors.initials: J
authors.lastname: Kempfert
authors.forename: T
authors.initials: T
authors.lastname: Walther
authors.forename: C
authors.initials: C
authors.lastname: Hamm
mesh_terms: D001021:Aortic Valve / Q000601:surgery*; D001024:Aortic Valve Stenosis / Q000175:diagnosis* / Q000601:surgery*; D006350:Heart Valve Prosthesis; D019918:Heart Valve Prosthesis Implantation / Q000295:instrumentation* / Q000379:methods*; D006801:Humans; D011474:Prosthesis Design